Sanaria is a biotechnology company dedicated to the production of a vaccine protective against malaria caused by the pathogen Plasmodium falciparum. Sanaria’s vaccine is based on an approach to immunization that has already proven highly protective in humans.

Biotechnology

Sanaria Inc.

Dr. Stephen L. Hoffman

Stephen Hoffman

The Leadership Team at Sanaria Inc. is responsible for guiding the strategic vision and operational execution of the company’s mission to develop a malaria vaccine. Comprising top executives, including the CEO and Managing Directors, they oversee research initiatives, foster partnerships, and ensure alignment with regulatory standards, driving innovation and maximizing the impact of Sanaria’s groundbreaking work in biotechnology.

Leadership Team

About

Team members

Other teams at Sanaria Inc.

Research and Development

Quality Assurance and Compliance